Two-stage blood algorithm reduces amyloid PET use in validated Alzheimer’s triage study
An externally validated two-stage blood-biomarker algorithm reduced the need for amyloid PET by resolving more uncertain p-Tau217 results while retaining ...
An externally validated two-stage blood-biomarker algorithm reduced the need for amyloid PET by resolving more uncertain p-Tau217 results while retaining ...
A meta-analysis of 37 real-world lecanemab studies found ARIA in 15.1% of cases, with higher rates among APOE ε4 homozygotes ...
An automated Roche p-tau217 blood test showed high accuracy for identifying brain amyloid pathology and placed 88.1% of a Taiwanese ...
A new Nature Communications study shows that plasma eMTBR-tau243 and p-tau205 rise during the later tau aggregation stage of Alzheimer's ...
An international study of 726 patients links novel SPG4/SPAST mutations to a rare plaque-only form of early-onset dementia, expanding the ...
A new eight-year study of 145 memory clinic patients shows that amyloid PET scans reliably predict conversion to Alzheimer's disease ...
New ahead-of-print studies in The Journal of Nuclear Medicine showcase immune-cell PET imaging, long-acting radiopharmaceutical therapies, and validated quantitative PET ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine